Beaird Harris Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1K Hold
34
﹤0.01% 371
2026
Q1
$9.9K Hold
34
﹤0.01% 366
2025
Q4
$11.9K Hold
34
﹤0.01% 382
2025
Q3
$11K Sell
34
-10
-23% -$3.11K ﹤0.01% 378
2025
Q2
$17K Buy
44
+4
+10% +$1.61K ﹤0.01% 342
2025
Q1
$17.4K Hold
40
﹤0.01% 321
2024
Q4
$14.8K Sell
40
-18
-31% -$7.53K ﹤0.01% 324
2024
Q3
$30.2K Hold
58
﹤0.01% 268
2024
Q2
$31.5K Hold
58
﹤0.01% 261
2024
Q1
$30.1K Sell
58
-10
-15% -$4.97K ﹤0.01% 241
2023
Q4
$32.1K Buy
+68
New +$31.4K ﹤0.01% 216
2023
Q1
Sell
-40
Closed -$20.5K 558
2022
Q4
$20.5K Buy
+40
New +$20.3K ﹤0.01% 253
2022
Q2
Sell
-33
Closed -$16K 466
2022
Q1
$16K Buy
+33
New +$15.1K 0.01% 272

Other funds holding ELV

Beaird Harris Wealth Management's ELV Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Elevance Health (ELV) position steady in Q2 2026 at 34 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Beaird Harris Wealth Management first reported a position in ELV in Q1 2022 and has held it in 13 quarters since. The position peaked at $32.1K in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Beaird Harris Wealth Management held 34 shares of Elevance Health worth $13.1K as of Q2 2026.
  • Beaird Harris Wealth Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #371 holding.
  • Beaird Harris Wealth Management first reported a position in Elevance Health in Q1 2022 and has held it in 13 quarters since.
  • Beaird Harris Wealth Management's Elevance Health position peaked at $32.1K in Q4 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.